( and clinical workis a collaboration o...)Beike Biotechnology Study Suggests Adult Stem Cells Show Promise,for Peripheral Vascular Disease,Health

and clinical work is a collaboration of Beijing University, Hong Kong University of Science and Technology, China's No. 3 Army Medical University, Zhongshan Medical University, Guiyang Medical College, Shenyang 463 Hospital and Zhengzhou University. Since 2001, Beike has treated over 1,800 patients with adult and umbilical cord stem cells for neurological and vascular diseases.

The abstract of this study on treatment of peripheral vascular disease can be found at: http://www.jgeriatriccard.com/id10abstract-september06.html.

    Contact:

    Dr. Sean Hu - Chairman

    Beike Biotech Co., Ltd.

    Shenzhen Hi-Tech Industrial Park

    +8613573828887

    

    http://www.beikebiotech.com

info@beikebiotech.com

This release was issued through eReleases(TM). For more information, visit http://www.ereleases.com.

CONTACT: Dr. Sean Hu - Chairman of Beike Biotech Co., Ltd.,+8613573828887, info@beikebiotech.com

Web site: http://www.beikebiotech.com/http://www.stemcellschina.com//

Terms and conditions of use apply
Copyright © 2007 PR Newswire Association LLC. All rights reserved.
A United Business Media Company

'"/>




Page: 1 2 3
Related medicine technology :

1. Generex Biotechnology to Make Presentations At 46th Annual Meeting of the European Society of Pediatric Endocrinology
2. Cougar Biotechnology Announces Presentation of Positive CB7630 Clinical Data at ESMO Conference
3. Cytos Biotechnology Reports Results from Phase IIa Study with CYT003-QbG10 in Patients Suffering from Atopic Dermatitis
4. Prana Biotechnology Presents New Key Findings on PBT2
5. Cougar Biotechnology Announces Presentation of Positive CB7630 Clinical Data at ASCO Annual Meeting
6. Generex Biotechnology Vaccine Strategy Presented at International Conference in London
7. Cougar Biotechnology Announces Presentation of Positive CB7630 Clinical Data at AUA Annual Meeting
8. Cougar Biotechnology Presents Positive CB7630 Clinical Data at AACR Annual Meeting Late-Breaking Clinical Trials Session
9. Data Available From Erbitux Phase III Study in First-Line Treatment of Advanced Lung Cancer
10. Clinical Study Shows Regenecare Relieves Pain and Itching of Skin Rashes Caused by Widely Used Cancer Drugs
11. Cell Therapeutics, Inc. Management to Discuss Todays Announcement of Interim Pixantrone Study Results